ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,286.22
0.05%
Dow Jones
38,718.18
0.38%
US Dollar vs MXN
17.88071
1.00%
Brent Oil
77.66
-0.61%
Bitcoin
70,843.31
2.96%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Axogen Inc (AXGN)

  7. Axogen Inc (AXGN) Noticias

AXGN Axogen Inc

6.69
-0.13 (-1.91%)
Última actualización: 13:01:27
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Axogen Inc AXGN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.13 -1.91% 6.69 13:01:27
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
6.78 6.57 6.81 6.82
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
28/5/202415:30GLOBEAxogen Processing Center (APC) Celebrates its Opening with..
16/5/202406:00GLOBEAxogen Inc. Initiates Rolling Submission of Biologics..
14/5/202406:00GLOBEAxogen, Inc to Participate at Leerink Partners Healthcare..
02/5/202406:00GLOBEAxogen, Inc Reports First Quarter 2024 Financial Results
29/4/202415:50GLOBEAxogen Announces First Surgical Implants of Avive+ Soft..
16/4/202406:00GLOBEAxogen, Inc. to Report First Quarter 2024 Financial Results..
08/3/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:38EDGAR2Form 8-K - Current report
07/3/202417:12EDGAR2Form 144 - Report of proposed sale of securities
07/3/202415:18EDGAR2Form 144 - Report of proposed sale of securities
06/3/202407:59EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202407:53EDGAR2Form S-3 - Registration statement under Securities Act of..
06/3/202407:45EDGAR2Form POS AM - Post-Effective amendments for registration..
05/3/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:29EDGAR2Form 8-K - Current report
05/3/202406:16EDGAR2Form 8-K - Current report
05/3/202406:00GLOBEAxogen, Inc Reports 2023 Fourth Quarter and Full-Year..
23/2/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202415:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202414:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:30GLOBEAxogen, Inc. to Report 2023 Fourth Quarter and Full-Year..
12/2/202412:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202416:06EDGAR2Form 144 - Report of proposed sale of securities
02/2/202415:15GLOBECompany Reports Inducement Grants Under Nasdaq Listing Rule..
02/2/202408:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202416:00GLOBEAxogen, Inc. Announces Positive Topline Results from REPOSE,..
11/1/202416:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202416:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/1/202416:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202406:05EDGAR2Form 8-K - Current report
05/1/202416:21EDGAR2Form 8-K/A - Current report: [Amend]
04/1/202416:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/1/202415:56EDGAR2Form 8-K - Current report
04/1/202415:45GLOBEAxogen Reports Preliminary Unaudited Revenue for Fourth..
04/1/202415:40GLOBEAxogen Announces Plan for Leadership Transition with CEO..
04/1/202415:35GLOBEAxogen Announces Promotions on Research and Development Team
26/12/202315:21EDGAR2Form 8-K - Current report
26/12/202315:15GLOBEAxogen, Inc. Appoints Kathy Weiler to its Board of Directors
13/12/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202315:38EDGAR2Form 144 - Report of proposed sale of securities
06/12/202306:15EDGAR2Form 8-K - Current report
06/12/202306:00GLOBEAxogen Announces Transition of Finance Team Leadership
01/12/202316:00GLOBECompany Reports Inducement Grants Under Nasdaq Listing Rule..
20/11/202306:00GLOBEAxogen, Inc. to Participate at the Piper Sandler 35th Annual..
07/11/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:13EDGAR2Form 8-K - Current report
07/11/202306:00GLOBEAxogen, Inc. Reports 2023 Third Quarter Financial Results

Su Consulta Reciente

NASDAQ
AXGN
Axogen
LSE
EG94
Mitsu Hc Cap 24
LSE
34AI
Stagecoach.25
USOTC
DADTF
Datadot Technology (PK)
LSE
XQ97
Sse.perp
COIN
MXMEUR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados